DUBLIN–(BUSINESS WIRE)–The “HLA Typing Market by Product, by Technology, by Application, by End-Users, Geography Forecast up to 2026” report has been added to ResearchAndMarkets.com’s offering.

The HLA typing market is expected to reach USD 990.12 million by 2026 from USD 659.75 million in 2020, at a CAGR of ~7.0%.

The factors which are majorly driving this market are innovative technologies in the transplant procedures and increasing transplant procedures, a large number of research and development activities in this field of HLA Typing. Molecular tests include high expenses for the HLA typing test, which is standing as a constraint in this market.

Globally, HLA Typing market is playing a major role in the transplant diagnostic field, giving an accurate analysis of the person’s immune system for further transplantation process. An increase in the adoption of cross-matching and chimerism testing during post and pre-transplantation gives the opportunity in the market. However, due to the number of donors compared to donor accepters are very less, the market is facing a major challenge in the growth of the market.

There is a rapid growth in the demand for transplant diagnostic products due to factors such as public and private increased funding in target research activities. Majorly the increase in certain diseases such as blood cancers, genetic blood disorders where stem cell transplantation is required, this situation is expected to drive the HLA Typing market. However, the limited reimbursements for target procedures are a restrain for this market.

The global HLA (Human Leukocyte Antigen) Typing market is segmented based on end-user. (Read more…) The segment of independent reference laboratories accounted for the largest share in the market due to the increased demand for organ transplant procedures, improved and automated diagnostic laboratories, increasing research and development activities outsourced by pharmaceutical and biotechnology companies to independent reference laboratories.

The global HLA Typing market is segmented based on end-user. The independent reference laboratories segment, which accounted for the largest share in the market with increased demand for organ transplant procedures, improved and automated diagnostic laboratories, increasing research and development activities outsourced by pharmaceutical and biotechnology companies to independent reference laboratories.

Further, HLA Typing market segmentation based on product and service includes Reagents & Consumables, Instruments, Software & Services. In this market segment, reagents and consumables play a major role in the market growth because of the early patient profiling during organ transplantation.

Based on technology, the market is divided into molecular assay technologies and non- molecular technologies. By analysis, the molecular assay technology has the majority of the demand in the HLA typing. The molecular assay technology consumes less time as compared to other technology and gives effective results that support market growth.

Moreover, the HLA Typing market based on region is segmented into four regions, including North America, Europe, Asia Pacific, and RoW. Further, the North America region is accounted for the largest share of the transplant market due to the well-developed market for medical devices, highly improvised healthcare system, a rapid increase in the adoption of the innovative transplant diagnostic technologies.

Some of the prominent players in the HLA Typing Market are Thermo Fisher Scientific, Inc., Omixon, CareDx, Inc, QIAGEN N.V., Luminex, Biofortuna, Illumina, Bio-Rad Laboratories, Inc., Takara Bio, TBG Diagnostics Ltd., and F. Hoffman-La Roche Ltd.

Moreover, the awareness about organ donation and transplantation across the developing countries and emerging technologies are supporting the HLA Typing Market growth globally.

This report will enable the market players to understand the key market trends, market dynamics, and critical needs of the end-users. The qualitative and quantitative analysis covered in the study would enhance the user utility of the report.

Key Topics Covered:

Executive Summary

Industry Outlook

• Industry Overview
• Industry Trends

Market Snapshot

• Market Definition
• Market Outlook
• PEST Analysis
• Porter Five Forces
• Related Markets
• Market characteristics
• Market Evolution
• Market Trends and Impact
• Advantages/Disadvantages of Market
• Regulatory Impact
• Market Offerings
• Market Segmentation

Market Dynamics

• Drivers
• Restraints
• Opportunities
• DRO – Impact Analysis

Technology: Market Size & Analysis

• Overview
• Molecular Assay Technologies
• Non-molecular Assay Technologies

Application: Market Size & Analysis

• Overview
• Diagnostic Applications
• Antibody Screening
• Chimerism Monitoring
• Others
• Research Applications

Product: Market Size & Analysis

• Overview
• Reagents & Consumables
• Instruments
• Software & Services

End User: Market Size & Analysis

• Overview
• Independent Reference Laboratories
• Hospitals & Transplant Centers
• Research Laboratories & Academic Institutes

Geography: Market Size & Analysis

• Overview
• North America
• Europe
• Asia Pacific
• Rest of the World

Competitive Landscape

• Competitor Comparison Analysis
• Market Developments
• Mergers and Acquisitions, Legal, Awards, Partnerships
• Product Launches and execution

Vendor Profiles

• Thermo Fisher Scientific Inc.
• Overview
• Product Offerings
• Geographic Revenue
• Business Units
• Developments
• SWOT Analysis
• Business Strategy
• F. Hoffman-La Roche Limited
• Qiagen
• Immucor
• Abbott Laboratories Inc
• Luminex
• Biofortuna
• Omixon
• Creative Biolabs
• Tbg Diagnostics Limited

Companies to Watch

• Caredx, Inc.
• Overview
• Market
• Business Strategy
• Illumina
• Bio-Rad Laboratories
• Alpha Biotech, Ltd.
• Gendx
• Histogenetics Llc
• Pacific Biosciences of California, Inc.
• Hansa Biopharma Ab
• Bag Healthcare
• Takara Bio

Analyst Opinion

For more information about this report visit https://www.researchandmarkets.com/r/czxnov

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

DUBLIN–(BUSINESS WIRE)–The “HLA Typing Market by Product, by Technology, by Application, by End-Users, Geography Forecast up to 2026” report has been added to ResearchAndMarkets.com’s offering.

The HLA typing market is expected to reach USD 990.12 million by 2026 from USD 659.75 million in 2020, at a CAGR of ~7.0%.

The factors which are majorly driving this market are innovative technologies in the transplant procedures and increasing transplant procedures, a large number of research and development activities in this field of HLA Typing. Molecular tests include high expenses for the HLA typing test, which is standing as a constraint in this market.

Globally, HLA Typing market is playing a major role in the transplant diagnostic field, giving an accurate analysis of the person’s immune system for further transplantation process. An increase in the adoption of cross-matching and chimerism testing during post and pre-transplantation gives the opportunity in the market. However, due to the number of donors compared to donor accepters are very less, the market is facing a major challenge in the growth of the market.

There is a rapid growth in the demand for transplant diagnostic products due to factors such as public and private increased funding in target research activities. Majorly the increase in certain diseases such as blood cancers, genetic blood disorders where stem cell transplantation is required, this situation is expected to drive the HLA Typing market. However, the limited reimbursements for target procedures are a restrain for this market.

The global HLA (Human Leukocyte Antigen) Typing market is segmented based on end-user. (Read more…) The segment of independent reference laboratories accounted for the largest share in the market due to the increased demand for organ transplant procedures, improved and automated diagnostic laboratories, increasing research and development activities outsourced by pharmaceutical and biotechnology companies to independent reference laboratories.

The global HLA Typing market is segmented based on end-user. The independent reference laboratories segment, which accounted for the largest share in the market with increased demand for organ transplant procedures, improved and automated diagnostic laboratories, increasing research and development activities outsourced by pharmaceutical and biotechnology companies to independent reference laboratories.

Further, HLA Typing market segmentation based on product and service includes Reagents & Consumables, Instruments, Software & Services. In this market segment, reagents and consumables play a major role in the market growth because of the early patient profiling during organ transplantation.

Based on technology, the market is divided into molecular assay technologies and non- molecular technologies. By analysis, the molecular assay technology has the majority of the demand in the HLA typing. The molecular assay technology consumes less time as compared to other technology and gives effective results that support market growth.

Moreover, the HLA Typing market based on region is segmented into four regions, including North America, Europe, Asia Pacific, and RoW. Further, the North America region is accounted for the largest share of the transplant market due to the well-developed market for medical devices, highly improvised healthcare system, a rapid increase in the adoption of the innovative transplant diagnostic technologies.

Some of the prominent players in the HLA Typing Market are Thermo Fisher Scientific, Inc., Omixon, CareDx, Inc, QIAGEN N.V., Luminex, Biofortuna, Illumina, Bio-Rad Laboratories, Inc., Takara Bio, TBG Diagnostics Ltd., and F. Hoffman-La Roche Ltd.

Moreover, the awareness about organ donation and transplantation across the developing countries and emerging technologies are supporting the HLA Typing Market growth globally.

This report will enable the market players to understand the key market trends, market dynamics, and critical needs of the end-users. The qualitative and quantitative analysis covered in the study would enhance the user utility of the report.

Key Topics Covered:

Executive Summary

Industry Outlook

• Industry Overview
• Industry Trends

Market Snapshot

• Market Definition
• Market Outlook
• PEST Analysis
• Porter Five Forces
• Related Markets
• Market characteristics
• Market Evolution
• Market Trends and Impact
• Advantages/Disadvantages of Market
• Regulatory Impact
• Market Offerings
• Market Segmentation

Market Dynamics

• Drivers
• Restraints
• Opportunities
• DRO – Impact Analysis

Technology: Market Size & Analysis

• Overview
• Molecular Assay Technologies
• Non-molecular Assay Technologies

Application: Market Size & Analysis

• Overview
• Diagnostic Applications
• Antibody Screening
• Chimerism Monitoring
• Others
• Research Applications

Product: Market Size & Analysis

• Overview
• Reagents & Consumables
• Instruments
• Software & Services

End User: Market Size & Analysis

• Overview
• Independent Reference Laboratories
• Hospitals & Transplant Centers
• Research Laboratories & Academic Institutes

Geography: Market Size & Analysis

• Overview
• North America
• Europe
• Asia Pacific
• Rest of the World

Competitive Landscape

• Competitor Comparison Analysis
• Market Developments
• Mergers and Acquisitions, Legal, Awards, Partnerships
• Product Launches and execution

Vendor Profiles

• Thermo Fisher Scientific Inc.
• Overview
• Product Offerings
• Geographic Revenue
• Business Units
• Developments
• SWOT Analysis
• Business Strategy
• F. Hoffman-La Roche Limited
• Qiagen
• Immucor
• Abbott Laboratories Inc
• Luminex
• Biofortuna
• Omixon
• Creative Biolabs
• Tbg Diagnostics Limited

Companies to Watch

• Caredx, Inc.
• Overview
• Market
• Business Strategy
• Illumina
• Bio-Rad Laboratories
• Alpha Biotech, Ltd.
• Gendx
• Histogenetics Llc
• Pacific Biosciences of California, Inc.
• Hansa Biopharma Ab
• Bag Healthcare
• Takara Bio

Analyst Opinion

For more information about this report visit https://www.researchandmarkets.com/r/czxnov

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900